Clinical Trials Arena on MSN8d
Innovent Biologics doses first subject in trial of ovarian cancer therapyInnovent Biologics has dosed the first subject in the Phase III HeriCare-Ovarian01 trial of IBI354 for treating PROC with ...
China's armed forces have become a key factor and a vital force in United Nations (UN) peacekeeping efforts, experts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback